MARAGANORE JOHN
SEC insider (Form 3/4/5 filer). CIK 0001180432. Director at Rapport Therapeutics, Inc. (RAPP) and 5 other issuers. 15 reported Form 4/5 transactions since Sep 2024; latest on Oct 22, 2026. Located in CAMBRIDGE, MA.
Companies MARAGANORE JOHN has filed insider reports for
- Rapport Therapeutics, Inc. (RAPP): Director
- CITY THERAPEUTICS, INC. (CTY): Director
- TAKEDA PHARMACEUTICAL CO LTD (TAK): Director
- Kymera Therapeutics, Inc. (KYMR): Director
- Beam Therapeutics Inc. (BEAM): Director
- Hemab Therapeutics Holdings, Inc. (COAG): Director
MARAGANORE JOHN
CIK: 0001180432
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Oct 22, 2026RAPP
Rapport Therapeutics, Inc.
PurchaseIndirect8.2K shares at avg. $26.38$217K - Oct 22, 2026RAPP
Rapport Therapeutics, Inc.
PurchaseIndirect1.2K shares at avg. $26.92$32K - Oct 19, 2026CTY
CITY THERAPEUTICS, INC.
ConversionDirect610.8K shares- - Oct 15, 2026CTY
CITY THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
22.6K shares- - Jul 10, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
DispositionDirectTax Obligation Award
1.2K shares at avg. $4931.20- - Jul 1, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
AwardDirect3.8K shares- - Jun 24, 2026KYMR
Kymera Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
6.1K shares- - Jun 10, 2026RAPP
Rapport Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
15.2K shares- - Jun 3, 2026BEAM
Beam Therapeutics Inc.
AwardDirectStock Option (Right to Buy)
19.7K shares- - May 4, 2026COAG
Hemab Therapeutics Holdings, Inc.
ConversionDirect18K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 22, 2026 |  RAPP Rapport Therapeutics, Inc. | Purchase | 8,239 | $26.38 | $217,344 | Indirect |
| Oct 22, 2026 | RAPP Rapport Therapeutics, Inc. | Purchase | 1,172 | $26.92 | $31,547 | Indirect |
| Oct 19, 2026 |  CTY CITY THERAPEUTICS, INC. | Conversion | 610,759 | - | $0 | Direct |
| Oct 15, 2026 | CTY CITY THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 22,649 | - | - | Direct |
| Jul 10, 2026 |  TAK TAKEDA PHARMACEUTICAL CO LTD | Disposition Tax Obligation Award | 1,152 | $4931.20 | - | Direct |
| Jul 1, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | Award | 3,800 | - | $0 | Direct |
| Jun 24, 2026 |  KYMR Kymera Therapeutics, Inc. | Award Stock Option (Right to Buy) | 6,068 | - | - | Direct |
| Jun 10, 2026 | RAPP Rapport Therapeutics, Inc. | Award Stock Option (Right to Buy) | 15,200 | - | - | Direct |
| Jun 3, 2026 |  BEAM Beam Therapeutics Inc. | Award Stock Option (Right to Buy) | 19,676 | - | - | Direct |
| May 4, 2026 |  COAG Hemab Therapeutics Holdings, Inc. | Conversion | 17,974 | - | $0 | Direct |
1-10 of 15 transactions